Related Experiment Videos

[Physiopathological and diagnostic value of genetic changes in digestive cancers]

P Laurent-Puig¹, J F Fléjou

¹Laboratoire de Génétique des Tumeurs, INSERM U 434, Institut Curie, Paris.

Gastroenterologie Clinique Et Biologique

|January 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a post hoc analysis of 2973 patients from two adjuvant randomized trials.

ESMO gastrointestinal oncology·2026

Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations.

ESMO gastrointestinal oncology·2026

Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.

ESMO open·2025

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.

European journal of cancer (Oxford, England : 1990)·2025

Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy.

European journal of cancer (Oxford, England : 1990)·2025

See all related articles